Proctosedyl suppository. New alternative listed: Scheriproct suppository

We are writing to inform you of -

Supply issue: Proctosedyl suppository.

New alternative listed: Scheriproct suppository.

Key messages:

• The supplier (AFT) has informed Pharmac that due to a delayed shipment that Proctosedyl suppositories are out of stock.

• Scheriproct suppositories have been listed (funded) on the Pharmaceutical Schedule.

• Scheriproct suppositories will be available in New Zealand by early April.

• Ultraproct suppositories have been out of stock for a long period. Pharmac has sourced this alternate product to help with both shortages.

Information about Scheriproct suppositories:

• The active ingredients in Scheriproct suppositories are cinchocaine hydrocholoride 1mg + prednisolone hexanoate 1.3mg

• The active ingredients in Proctosedyl suppositories are hydrocortisone 5 mg + cinchocaine hydrochloride 5 mg

• Please note this is a different product and will require a new prescription. A Recare prompt will be set up with a reminder about the new product as a potential alternative.

• Scheriproct suppositories need to be supplied and dispensed in line with Section 29A of the Medicines Act.

• For more information, please see Scheriproct suppositories on the Pharmac website.

Questions:

If you have any queries, please contact us at enquiry@pharmac.govt.nz

Please share this information:

Ngā mihi,

Anna I Senior Advisor Implementation

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz